Catapres (clonidine recalls

The FDA has published 3 recalls involving Catapres (clonidine since 2020. The latest was reported on 4 Nov 2020. Most were for foreign material. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls3since 2020

Last 12 months0reported

Class I00% of total

Ongoing0latest 4 Nov 2020

Recalls per month, last 24 months

click a bar for that month

0Dec '24 0 0 0Mar 0 0 0Jun 0 0 0Sep 0 0 0Dec 0 0 0Mar 0 0 0Jun 0 0 0Sep 0 0

Severity split

Class I 0 0%Class II 3 100%Class III 0 0%

Why catapres (clonidine is recalled

Foreign Material3100%

Companies

Boehringer Ingelheim Pharmaceuticals3100%

By year

20203100%

All catapres (clonidine recalls, newest first

3 total

Reported	Class	Recall	Company	Reason	Where
4 Nov 2020Drug	CLASS II	Catapres (clonidine hydrochloride, USP) 0.3 mg, tablet recalled	Boehringer Ingelheim Pharmaceuticals	Foreign Material	Nationwide
4 Nov 2020Drug	CLASS II	Catapres (clonidine hydrochloride, USP) 0.2 mg, tablet recalled	Boehringer Ingelheim Pharmaceuticals	Foreign Material	Nationwide
4 Nov 2020Drug	CLASS II	Catapres (clonidine hydrochloride, USP) 0.1 mg, tablet recalled	Boehringer Ingelheim Pharmaceuticals	Foreign Material	Nationwide

Should you stop taking Catapres (clonidine?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.